Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 9/20 | 0.35 |
| ▸ | HCRTR2 | O43614 | 9/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | PER2 | O15055 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | VNN1 | O95497 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17525626 | 0.76 | HSD17B10 (0.39) | CYP1A2CTDSP1 | |
| SCHEMBL19793343 | 0.75 | HCRTR2 (0.36) | HCRTR1HCRTR2 | |
| SCHEMBL19780652 | 0.73 | NPC1 (0.38) | HCRTR1HCRTR2 | |
| SCHEMBL19793300 | 0.73 | KDM4E (0.34) | HCRTR1HCRTR2 | |
| SCHEMBL20880132 | 0.70 | TERT (0.39) | — | |
| SCHEMBL22538918 | 0.70 | FDPS (0.35) | HCRTR1HCRTR2CHRM2CHRM1CHRM3 | |
| SCHEMBL25615350 | 0.70 | — | — | |
| SCHEMBL20880100 | 0.68 | HCRTR1 (0.53) | HCRTR1HCRTR2 | |
| SCHEMBL22538976 | 0.68 | EPHX1 (0.40) | HCRTR1HCRTR2HRH3 | |
| SCHEMBL19793288 | 0.68 | HDAC1 (0.44) | PER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9815814-B2 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives | Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” (RU) | 2017-11-14 | — | — | US | disclosed |